Business
Westlake manufactures chemicals, vinyls, polymers and building products used in housing, infrastructure and consumer applications.
Westlake's revenue contraction, large loss and negative free cash flow reflected a severe chemical downturn, with facility-shutdown impairments confirming excess capacity.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 8.0%Watch
- Profitability — The company moved from net income of $602M to a net loss of $1.508BWatch
- Cash flow — Free cash flow turned negative at an outflow of $530M from $306MWatch
- Margins — Operating margin contracted 2134 bps to -14.13%Watch
- Accounting — Cyclical chemical stress with impairmentsWatch
- Insiders — 0 purchases and 4 salesNote
Where the revenue comes from
Fiscal 2025, as WESTLAKE CORP reports it. History and quarterly detail are in the app.
- Performance and Essential Materials$7.0B
- Housing and Infrastructure Products$4.1B
Leadership changes
From WESTLAKE CORP's own filings, the day they're filed.
- M. Steven Bender · Chief Financial Officer · appointmenteff. 2026-06-15
- Jonathan H. Baksht · President · appointmenteff. 2026-06-15
- Brian Powers · President · appointmenteff. 2026-04-02
Latest filings
- 8-K · Company announcement2026-08-31
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-06-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about WESTLAKE CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.